S&P 500   4,248.72 (+0.91%)
DOW   33,595.05 (+0.86%)
QQQ   330.05 (+1.26%)
AAPL   170.68 (+0.85%)
MSFT   290.35 (+0.41%)
META   182.76 (+2.48%)
GOOGL   121.39 (+1.41%)
AMZN   144.31 (+1.14%)
TSLA   882.12 (-0.11%)
NVDA   186.10 (+2.83%)
NIO   21.70 (+8.23%)
BABA   97.34 (+5.31%)
AMD   102.01 (+2.99%)
MU   63.83 (+3.96%)
T   18.15 (+0.78%)
CGC   3.42 (+3.95%)
GE   78.55 (+1.83%)
F   15.76 (+1.68%)
DIS   121.55 (+8.11%)
AMC   26.01 (+9.89%)
PYPL   101.66 (+2.78%)
PFE   48.54 (-2.82%)
NFLX   250.59 (+2.65%)
S&P 500   4,248.72 (+0.91%)
DOW   33,595.05 (+0.86%)
QQQ   330.05 (+1.26%)
AAPL   170.68 (+0.85%)
MSFT   290.35 (+0.41%)
META   182.76 (+2.48%)
GOOGL   121.39 (+1.41%)
AMZN   144.31 (+1.14%)
TSLA   882.12 (-0.11%)
NVDA   186.10 (+2.83%)
NIO   21.70 (+8.23%)
BABA   97.34 (+5.31%)
AMD   102.01 (+2.99%)
MU   63.83 (+3.96%)
T   18.15 (+0.78%)
CGC   3.42 (+3.95%)
GE   78.55 (+1.83%)
F   15.76 (+1.68%)
DIS   121.55 (+8.11%)
AMC   26.01 (+9.89%)
PYPL   101.66 (+2.78%)
PFE   48.54 (-2.82%)
NFLX   250.59 (+2.65%)
S&P 500   4,248.72 (+0.91%)
DOW   33,595.05 (+0.86%)
QQQ   330.05 (+1.26%)
AAPL   170.68 (+0.85%)
MSFT   290.35 (+0.41%)
META   182.76 (+2.48%)
GOOGL   121.39 (+1.41%)
AMZN   144.31 (+1.14%)
TSLA   882.12 (-0.11%)
NVDA   186.10 (+2.83%)
NIO   21.70 (+8.23%)
BABA   97.34 (+5.31%)
AMD   102.01 (+2.99%)
MU   63.83 (+3.96%)
T   18.15 (+0.78%)
CGC   3.42 (+3.95%)
GE   78.55 (+1.83%)
F   15.76 (+1.68%)
DIS   121.55 (+8.11%)
AMC   26.01 (+9.89%)
PYPL   101.66 (+2.78%)
PFE   48.54 (-2.82%)
NFLX   250.59 (+2.65%)
S&P 500   4,248.72 (+0.91%)
DOW   33,595.05 (+0.86%)
QQQ   330.05 (+1.26%)
AAPL   170.68 (+0.85%)
MSFT   290.35 (+0.41%)
META   182.76 (+2.48%)
GOOGL   121.39 (+1.41%)
AMZN   144.31 (+1.14%)
TSLA   882.12 (-0.11%)
NVDA   186.10 (+2.83%)
NIO   21.70 (+8.23%)
BABA   97.34 (+5.31%)
AMD   102.01 (+2.99%)
MU   63.83 (+3.96%)
T   18.15 (+0.78%)
CGC   3.42 (+3.95%)
GE   78.55 (+1.83%)
F   15.76 (+1.68%)
DIS   121.55 (+8.11%)
AMC   26.01 (+9.89%)
PYPL   101.66 (+2.78%)
PFE   48.54 (-2.82%)
NFLX   250.59 (+2.65%)
NYSE:HUM

Humana - HUM Stock Forecast, Price & News

$481.36
-4.64 (-0.95%)
(As of 08/11/2022 10:16 AM ET)
Add
Compare
Today's Range
$479.35
$485.75
50-Day Range
$423.21
$495.31
52-Week Range
$351.20
$497.47
Volume
2,282 shs
Average Volume
853,942 shs
Market Capitalization
$60.92 billion
P/E Ratio
19.65
Dividend Yield
0.65%
Price Target
$508.61

Humana MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
5.1% Upside
$510.63 Price Target
Short Interest
Healthy
1.31% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.16mentions of Humana in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.75%
From $24.85 to $27.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Medical Sector

85th out of 1,108 stocks

Hospital & Medical Service Plans Industry

3rd out of 11 stocks

HUM stock logo

About Humana (NYSE:HUM) Stock

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Trading Down 0.4 %

Shares of HUM Stock opened at $486.00 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.53 and a quick ratio of 1.53. The company has a market cap of $61.51 billion, a price-to-earnings ratio of 19.84, a PEG ratio of 1.45 and a beta of 0.77. The stock has a 50 day simple moving average of $466.41 and a 200-day simple moving average of $445.11. Humana has a 1-year low of $351.20 and a 1-year high of $497.47.

Humana (NYSE:HUM - Get Rating) last announced its earnings results on Wednesday, July 27th. The insurance provider reported $8.67 earnings per share for the quarter, topping the consensus estimate of $7.67 by $1.00. The business had revenue of $23.66 billion during the quarter, compared to the consensus estimate of $23.44 billion. Humana had a return on equity of 18.42% and a net margin of 3.52%. The business's quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.89 EPS. On average, equities research analysts expect that Humana will post 24.85 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on HUM. Wells Fargo & Company boosted their price target on Humana from $512.00 to $514.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 25th. Loop Capital initiated coverage on Humana in a report on Thursday, June 16th. They set a "buy" rating and a $510.00 target price for the company. Oppenheimer lifted their target price on Humana from $510.00 to $520.00 and gave the stock an "outperform" rating in a report on Thursday, July 28th. Credit Suisse Group set a $548.00 target price on Humana in a report on Tuesday, July 19th. Finally, StockNews.com downgraded Humana from a "strong-buy" rating to a "buy" rating in a report on Friday, July 29th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, Humana currently has a consensus rating of "Moderate Buy" and an average price target of $510.63.

Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Stock News Headlines

Humana (NYSE:HUM) PT Raised to $494.00 at Morgan Stanley
Q4 2022 EPS Estimates for Humana Inc. (NYSE:HUM) Cut by Analyst
Humana (NYSE:HUM) PT Raised to $540.00 at SVB Leerink
Humana (NYSE:HUM) Price Target Raised to $529.00
Oppenheimer Increases Humana (NYSE:HUM) Price Target to $520.00
Are Investors Undervaluing Humana (HUM) Right Now?
See More Headlines
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Company Calendar

Ex-Dividend for 7/29 Dividend
6/29/2022
Last Earnings
7/27/2022
Dividend Payable
7/29/2022
Today
8/11/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Medical
CUSIP
44485910
Employees
95,500
Year Founded
1961

Price Target and Rating

Average Stock Price Forecast
$510.63
High Stock Price Forecast
$550.00
Low Stock Price Forecast
$415.00
Forecasted Upside/Downside
+5.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
17 Analysts

Profitability

Net Income
$2.93 billion
Pretax Margin
4.38%

Debt

Sales & Book Value

Annual Sales
$83.06 billion
Cash Flow
$25.98 per share
Book Value
$122.56 per share

Miscellaneous

Free Float
126,060,000
Market Cap
$60.92 billion
Optionable
Optionable
Beta
0.77

Social Links


Key Executives














HUM Stock - Frequently Asked Questions

Should I buy or sell Humana stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 5 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HUM shares.
View HUM analyst ratings
or view top-rated stocks.

What is Humana's stock price forecast for 2022?

17 Wall Street analysts have issued 1 year price targets for Humana's stock. Their HUM share price forecasts range from $415.00 to $550.00. On average, they predict the company's stock price to reach $510.63 in the next twelve months. This suggests a possible upside of 5.1% from the stock's current price.
View analysts price targets for HUM
or view top-rated stocks among Wall Street analysts.

How have HUM shares performed in 2022?

Humana's stock was trading at $463.86 at the beginning of 2022. Since then, HUM stock has increased by 4.8% and is now trading at $486.00.
View the best growth stocks for 2022 here
.

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our HUM earnings forecast
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, July, 27th. The insurance provider reported $8.67 earnings per share for the quarter, beating analysts' consensus estimates of $7.67 by $1.00. The insurance provider had revenue of $23.66 billion for the quarter, compared to the consensus estimate of $23.44 billion. Humana had a net margin of 3.52% and a trailing twelve-month return on equity of 18.42%. The company's quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.89 earnings per share.
Read the conference call transcript
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 21st. Investors of record on Thursday, June 30th will be paid a dividend of $0.7875 per share on Friday, July 29th. This represents a $3.15 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Wednesday, June 29th.
Read our dividend analysis for HUM
.

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.15 per share and currently has a dividend yield of 0.65%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 12.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $24.75-$24.75 for the period, compared to the consensus earnings per share estimate of $24.63. The company issued revenue guidance of -.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Lazard Asset Management LLC (0.79%), Allspring Global Investments Holdings LLC (0.67%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), Jennison Associates LLC (0.32%) and Ceredex Value Advisors LLC (0.30%). Insiders that own company stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Jorge S Mesquita, Samir Deshpande, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends
.

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $486.00.

How much money does Humana make?

Humana (NYSE:HUM) has a market capitalization of $61.51 billion and generates $83.06 billion in revenue each year. The insurance provider earns $2.93 billion in net income (profit) each year or $24.50 on an earnings per share basis.

How many employees does Humana have?

The company employs 95,500 workers across the globe.

Does Humana have any subsidiaries?

The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More

When was Humana founded?

Humana was founded in 1961.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The official website for the company is www.humana.com. The insurance provider can be reached via phone at (502) 580-1000, via email at amysmith@humana.com, or via fax at 502-580-3639.

This page (NYSE:HUM) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.